Development of new monitoring system of antibody drug in human plasma by liquid chromatography-mass spectrometry using CDR-peptide selective proteolysis nSMOL

Noriko Iwamoto

[P26-8-6] Development of new monitoring system of antibody drug in human plasma by liquid chromatography-mass spectrometry using CDR-peptide selective proteolysis nSMOL

Noriko Iwamoto¹, Megumi Takanashi², Takashi Shimada³, Akinobu Hamada⁴ (1.Shimadzu Corporation, 2.Shimadzu Corporation, 3.Shimadzu Corporation, 4.National Cancer Center Research Institute)

キーワード：Antibody drug, Monitoring, nSMOL, LCMS, Bioanalysis

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

講演情報

[P26-8] P26-8: Oncologic drugs (4): Pharmacokinetics, TDM practice

[P26-8-6] Development of new monitoring system of antibody drug in human plasma by liquid chromatography-mass spectrometry using CDR-peptide selective proteolysis nSMOL

パスワード